Found 1711 results for "cancer"
Across 676 studies enrolling roughly 180 million participants, active cancer prevalence in cardiovascular disease patients ranges from 4.22% in type 2…
Senescent keratinocytes, fibroblasts, and melanocytes that resist clearance accumulate in aged skin and secrete the senescence-associated secretory phenotype…
Nasopharyngeal carcinoma linked to Epstein-Barr virus remains notoriously difficult to treat, with limited targeted options and significant toxicity from…
Understanding where cancer stands globally in 2024 reframes how individuals and health systems should think about lifetime risk — because the numbers now…
Esophageal squamous cell carcinoma carries one of the grimmer prognoses in oncology, partly because its molecular drivers remain incompletely mapped…
For decades, chronic low-grade inflammation in aging adults was treated as a background condition — an unfortunate byproduct of getting older. Emerging…
Breast cancer diagnosed during or shortly after pregnancy is one of oncology's most vexing challenges — aggressive, understudied, and affecting women at the…
Understanding why Americans struggle to eat well — not just whether they have enough food — may be one of the most actionable levers in chronic disease…
For the estimated millions of cancer survivors living with chemotherapy-related cognitive impairment — colloquially called 'chemo brain' — the absence of…
For oncologists and patients navigating aggressive cancers, a fundamental question has always been: why do some tumors evolve so rapidly and resist treatment…
Cell-based drug delivery is one of oncology's most promising frontiers, and a critical safety signal from this first-in-human trial offers a sobering but…
Thymic involution — the progressive shrinkage of the thymus beginning in adolescence — depletes naïve T-cell output, collapses T-cell receptor (TCR)…
GLP-1 receptor agonists — the drug class including semaglutide and liraglutide — appear to reduce risk across at least six obesity-related cancers: prostate…
Colorectal cancer's stubborn lethality stems partly from how tumor cells hijack lipid metabolism to fuel their own growth — and a new molecular target in that…
As cancer survival rates climb to historic highs, a growing population of long-term survivors is living with side effects that clinical trials were never…
For patients and clinicians hoping that a simple blood draw—or saliva sample, or breath test—could reliably detect lung cancer early, the gap between…
Gastric cancer remains one of the most lethal yet preventable malignancies in adults, and the question of whether routine colorectal screening programs could…
Gastric cancer kills roughly one million people annually worldwide, yet it remains chronically under-screened in Western primary care — largely because…
For the roughly one in five ovarian cancer patients first diagnosed through emergency care rather than planned clinical pathways, the consequences extend far…
For adults diagnosed with aggressive blood cancers, the promise of targeted immunotherapy can be undermined by the tumor's ability to shed the very protein…